
Invesco Pharmaceuticals ETF (PJP)
AMEX
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.728 | 0.664 | 4.149 | -0.817 | 22.19 | -0.998 | 2.289 | 0.023 |
Return on Equity (%) | 0.795 | 0.702 | 4.176 | -0.828 | 22.598 | -1.094 | 2.652 | 0.027 |
Return on Invested Capital (%) | -9.169 | -12.958 | -197.84 | -72.287 | -45.972 | -11.182 | -5.686 | -6.64 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 60.707 | 61.492 | 62.645 | 62.543 | 78.105 | 75.944 | 77.564 | 77.203 |
Earnings Per Share | 0.61 | 0.53 | 2.959 | -0.561 | 17.601 | -0.88 | 2.107 | 0.022 |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | -5.2 | -0.512 | -0.149 | -1.464 | -0.706 | -14.461 | -9.604 | -12.831 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 1.301 | 1.086 | 3.768 | 0.052 | 18.208 | -0.051 | 2.896 | 0.818 |
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 12,6M | 8,55M | 6,65M | 5,7M | 4,59M | 4,22M | 3,94M | 3,42M |
Fin d'année 30 Avril 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 291,46M |
Ratio cours/bénéfice | 3,82k |
Ratio prix/ventes | 67,89 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 1,1 |
Rendement de dividende | 86,91% |
Actions en circulation | 3,42M |
Volume moyen (1 semaine) | 5,95k |
Volume moyen (1 mois) | 5,67k |
Variation sur 52 semaines | 8,16% |
Plus haut sur 52 semaines | 89,87 |
Plus bas sur 52 semaines | 75,326 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales